Xenetic Biosciences Inc. (XBIO)
NASDAQ · Healthcare
Xenetic Biosciences Inc. Operating Income 2012–2025
Xenetic Biosciences Inc. annual/quarterly operating income history and growth rate from 2012 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Xenetic Biosciences Inc. operating income for the quarter ending March 31, 2026 was -502117, a 46.72% decrease year-over-year.
- Xenetic Biosciences Inc. operating income for the twelve months ending March 31, 2026 was -2.7 M, a 36.18% decrease year-over-year.
- Xenetic Biosciences Inc. annual operating income for 2025 was -2.8 M, a 32.58% decrease from 2024.
- Xenetic Biosciences Inc. annual operating income for 2024 was -4.2 M, a 6.89% decrease from 2023.
- Xenetic Biosciences Inc. annual operating income for 2023 was -4.5 M, a 32.78% decrease from 2022.
- Xenetic Biosciences Inc. annual operating income for 2022 was -6.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Xenetic Biosciences Inc. Operating Income — FAQ
Xenetic Biosciences Inc. (XBIO) operating income over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Xenetic Biosciences Inc.'s operating income?
Xenetic Biosciences Inc. (XBIO) reported operating income of -$3M for fiscal 2025.
Where can I see XBIO's operating income history?
The chart and table above show Xenetic Biosciences Inc.'s operating income by year and by quarter, including the growth rate.